{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:25:38Z","timestamp":1790749538765,"version":"4.1.0"},"reference-count":69,"publisher":"Japan Endocrine Society","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2012]]},"DOI":"10.1507\/endocrj.ej12-0322","type":"journal-article","created":{"date-parts":[[2012,9,15]],"date-time":"2012-09-15T10:14:17Z","timestamp":1347704057000},"page":"955-962","source":"Crossref","is-referenced-by-count":74,"title":["Essential roles of growth hormone (GH) and insulin-like growth factor-I (IGF-I) in the liver [Review]"],"prefix":"10.1507","volume":"59","author":[{"given":"Yutaka","family":"Takahashi","sequence":"first","affiliation":[{"name":"Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","unstructured":"1. Johannsson G, Bengtsson BA (1999) Growth hormone and the metabolic syndrome. <i>J Endocrinol Invest<\/i> 22: 41-46."},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2007.02195.x"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1210\/er.2009-0033"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Svensson J, Bengtsson BA, Rosen T, Oden A, Johannsson G (2004) Malignant disease and cardiovascular morbidity in hypopituitary adults with or without growth hormone replacement therapy. <i>J Clin Endocrinol Metab<\/i> 89: 3306-3312.","DOI":"10.1210\/jc.2003-031601"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Angulo P (2002) Nonalcoholic fatty liver disease. <i>N Engl J Med<\/i> 346: 1221-1231.","DOI":"10.1056\/NEJMra011775"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Hashimoto E, Tokushige K (2011) Prevalence, gender, ethnic variations, and prognosis of NASH. <i>J Gastroenterol<\/i> 46 Suppl 1: 63-69.","DOI":"10.1007\/s00535-010-0311-8"},{"key":"7","unstructured":"7. Adams LA, Talwalkar JA (2006) Diagnostic evaluation of nonalcoholic fatty liver disease. <i>J Clin Gastroenterol<\/i> 40 Suppl 1: S34-38."},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1872-034X.2012.00986.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Adams LA, Angulo P, Lindor KD (2005) Nonalcoholic fatty liver disease. <i>CMAJ<\/i> 172: 899-905.","DOI":"10.1503\/cmaj.045232"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.15.6983"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1210\/er.2008-0027"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(93)90285-V"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-5491.2003.00827.x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Simpson HL, Jackson NC, Shojaee-Moradie F, Jones RH, Russell-Jones DL, Sonksen PH, Dunger DB, Umpleby AM (2004) Insulin-like growth factor I has a direct effect on glucose and protein metabolism, but no effect on lipid metabolism in type 1 diabetes. <i>J Clin Endocrinol Metab<\/i> 89: 425-432.","DOI":"10.1210\/jc.2003-031274"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1172\/JCI17763"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2009.04.002"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1136\/adc.76.6.537"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.49.597"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1136\/gut.52.6.914"},{"key":"20","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20140"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.K08E-079"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.12.024"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1055\/s-0030-1265217"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Ichikawa T, Nakao K, Hamasaki K, Furukawa R, Tsuruta S, Ueda Y, Taura N, Shibata H, Fujimoto M, Toriyama K, Eguchi K (2007) Role of growth hormone, insulin-like growth factor 1 and insulin-like growth factor-binding protein 3 in development of non-alcoholic fatty liver disease. <i>Hepatol Int<\/i> 1: 287-294.","DOI":"10.1007\/s12072-007-9007-4"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-12-0252"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-12-0002"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Vernon G, Baranova A, Younossi ZM (2011) Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. <i>Aliment Pharmacol Ther<\/i> 34: 274-285.","DOI":"10.1111\/j.1365-2036.2011.04724.x"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Franco C, Brandberg J, Lonn L, Andersson B, Bengtsson BA, Johannsson G (2005) Growth hormone treatment reduces abdominal visceral fat in postmenopausal women with abdominal obesity: a 12-month placebo-controlled trial. <i>J Clin Endocrinol Metab<\/i> 90: 1466-1474.","DOI":"10.1210\/jc.2004-1657"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Donaghy A, Ross R, Wicks C, Hughes SC, Holly J, Gimson A, Williams R (1997) Growth hormone therapy in patients with cirrhosis: a pilot study of efficacy and safety. <i>Gastroenterology<\/i> 113: 1617-1622.","DOI":"10.1053\/gast.1997.v113.pm9352864"},{"key":"30","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1373.2000.22349.x"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Yakar S, Rosen CJ, Beamer WG, Ackert-Bicknell CL, Wu Y, Liu JL, Ooi GT, Setser J, Frystyk J, Boisclair YR, LeRoith D (2002) Circulating levels of IGF-1 directly regulate bone growth and density. <i>J Clin Invest<\/i> 110: 771-781.","DOI":"10.1172\/JCI0215463"},{"key":"32","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.13.7324"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Fan Y, Menon RK, Cohen P, Hwang D, Clemens T, DiGirolamo DJ, Kopchick JJ, Le Roith D, Trucco M, Sperling MA (2009) Liver-specific deletion of the growth hormone receptor reveals essential role of growth hormone signaling in hepatic lipid metabolism. <i>J Biol Chem<\/i> 284: 19937-19944.","DOI":"10.1074\/jbc.M109.014308"},{"key":"34","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.1350059"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Krupczak-Hollis K, Wang X, Dennewitz MB, Costa RH (2003) Growth hormone stimulates proliferation of old-aged regenerating liver through forkhead box m1b. <i>Hepatology<\/i> 38: 1552-1562.","DOI":"10.1053\/jhep.2003.08052"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Pennisi PA, Kopchick JJ, Thorgeirsson S, LeRoith D, Yakar S (2004) Role of growth hormone (GH) in liver regeneration. <i>Endocrinology<\/i> 145: 4748-4755.","DOI":"10.1210\/en.2004-0655"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Sos BC, Harris C, Nordstrom SM, Tran JL, Balazs M, Caplazi P, Febbraio M, Applegate MA, Wagner KU, Weiss EJ (2011) Abrogation of growth hormone secretion rescues fatty liver in mice with hepatocyte-specific deletion of JAK2. <i>J Clin Invest<\/i> 121: 1412-1423.","DOI":"10.1172\/JCI42894"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Barclay JL, Nelson CN, Ishikawa M, Murray LA, Kerr LM, McPhee TR, Powell EE, Waters MJ (2011) GH-dependent STAT5 signaling plays an important role in hepatic lipid metabolism. <i>Endocrinology<\/i> 152: 181-192.","DOI":"10.1210\/en.2010-0537"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Laron Z, Ginsberg S, Webb M (2008) Nonalcoholic fatty liver in patients with Laron syndrome and GH gene deletion - preliminary report. <i>Growth Horm IGF Res<\/i> 18: 434-438.","DOI":"10.1016\/j.ghir.2008.03.003"},{"key":"40","doi-asserted-by":"publisher","DOI":"10.1016\/0270-9139(95)90518-9"},{"key":"41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1995.tb02031.x"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Clemmons DR, Klibanski A, Underwood LE, McArthur JW, Ridgway EC, Beitins IZ, Van Wyk JJ (1981) Reduction of plasma immunoreactive somatomedin C during fasting in humans. <i>J Clin Endocrinol Metab<\/i> 53: 1247-1250.","DOI":"10.1210\/jcem-53-6-1247"},{"key":"43","doi-asserted-by":"publisher","DOI":"10.1172\/JCI113451"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Stefano JT, Correa-Giannella ML, Ribeiro CM, Alves VA, Massarollo PC, Machado MC, Giannella-Neto D (2006) Increased hepatic expression of insulin-like growth factor-I receptor in chronic hepatitis C. <i>World J Gastroenterol<\/i> 12: 3821-3828.","DOI":"10.3748\/wjg.v12.i24.3821"},{"key":"45","unstructured":"45. Kim SO, Park JG, Lee YI (1996) Increased expression of the insulin-like growth factor I (IGF-I) receptor gene in hepatocellular carcinoma cell lines: implications of IGF-I receptor gene activation by hepatitis B virus X gene product. <i>Cancer Res<\/i> 56: 3831-3836."},{"key":"46","unstructured":"46. Tao X, Shen D, Ren H, Zhang X, Zhang D, Ye J, Gu B (2000) Hepatitis B virus X protein activates expression of IGF-IR and VEGF in hepatocellular carcinoma cells. <i>Zhonghua Gan Zang Bing Za Zhi<\/i> 8: 161-163 (In Chinese)."},{"key":"47","doi-asserted-by":"publisher","DOI":"10.1177\/0192623310396905"},{"key":"48","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2012.05.115"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Bailyes EM, Nave BT, Soos MA, Orr SR, Hayward AC, Siddle K (1997) Insulin receptor\/IGF-I receptor hybrids are widely distributed in mammalian tissues: quantification of individual receptor species by selective immunoprecipitation and immunoblotting. <i>Biochem J<\/i> 327 (Pt 1): 209-215.","DOI":"10.1042\/bj3270209"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Smith BW, Adams LA (2011) Non-alcoholic fatty liver disease. <i>Crit Rev Clin Lab Sci<\/i> 48: 97-113.","DOI":"10.3109\/10408363.2011.596521"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Yakar S, Liu JL, Fernandez AM, Wu Y, Schally AV, Frystyk J, Chernausek SD, Mejia W, Le Roith D (2001) Liver-specific igf-1 gene deletion leads to muscle insulin insensitivity. <i>Diabetes<\/i> 50: 1110-1118.","DOI":"10.2337\/diabetes.50.5.1110"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Conchillo M, de Knegt RJ, Payeras M, Quiroga J, Sangro B, Herrero JI, Castilla-Cortazar I, Frystyk J, Flyvbjerg A, Yoshizawa C, Jansen PL, Scharschmidt B, Prieto J (2005) Insulin-like growth factor I (IGF-I) replacement therapy increases albumin concentration in liver cirrhosis: results of a pilot randomized controlled clinical trial. <i>J Hepatol<\/i> 43: 630-636.","DOI":"10.1016\/j.jhep.2005.03.025"},{"key":"53","doi-asserted-by":"publisher","DOI":"10.1007\/s10495-011-0634-9"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. Puche JE, Garcia-Fernandez M, Muntane J, Rioja J, Gonzalez-Baron S, Castilla Cortazar I (2008) Low doses of insulin-like growth factor-I induce mitochondrial protection in aging rats. <i>Endocrinology<\/i> 149: 2620-2627.","DOI":"10.1210\/en.2007-1563"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Perez R, Garcia-Fernandez M, Diaz-Sanchez M, Puche JE, Delgado G, Conchillo M, Muntane J, Castilla-Cortazar I (2008) Mitochondrial protection by low doses of insulin-like growth factor- I in experimental cirrhosis. <i>World J Gastroenterol<\/i> 14: 2731-2739.","DOI":"10.3748\/wjg.14.2731"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. Cheng Z, Guo S, Copps K, Dong X, Kollipara R, Rodgers JT, Depinho RA, Puigserver P, White MF (2009) Foxo1 integrates insulin signaling with mitochondrial function in the liver. <i>Nat Med<\/i> 15: 1307-1311.","DOI":"10.1038\/nm.2049"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57. Sanz S, Pucilowska JB, Liu S, Rodriguez-Ortigosa CM, Lund PK, Brenner DA, Fuller CR, Simmons JG, Pardo A, Martinez-Chantar ML, Fagin JA, Prieto J (2005) Expression of insulin-like growth factor I by activated hepatic stellate cells reduces fibrogenesis and enhances regeneration after liver injury. <i>Gut<\/i> 54: 134-141.","DOI":"10.1136\/gut.2003.024505"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58. Lee UE, Friedman SL (2011) Mechanisms of hepatic fibrogenesis. <i>Best Pract Res Clin Gastroenterol<\/i> 25: 195-206.","DOI":"10.1016\/j.bpg.2011.02.005"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59. Fujii H, Kawada N (2012) Inflammation and fibrogenesis in steatohepatitis. <i>J Gastroenterol<\/i> 47: 215-225.","DOI":"10.1007\/s00535-012-0527-x"},{"key":"60","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510270513"},{"key":"61","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510290632"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62. Brenzel A, Gressner AM (1996) Characterization of insulin-like growth factor (IGF)-I-receptor binding sites during in vitro transformation of rat hepatic stellate cells to myofibroblasts. <i>Eur J Clin Chem Clin Biochem<\/i> 34: 401-409.","DOI":"10.1515\/cclm.1996.34.5.401"},{"key":"63","doi-asserted-by":"publisher","DOI":"10.1210\/en.138.11.4683"},{"key":"64","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.1997.v26.pm0009214455"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65. Arturi F, Succurro E, Procopio C, Pedace E, Mannino GC, Lugara M, Procopio T, Andreozzi F, Sciacqua A, Hribal ML, Perticone F, Sesti G (2011) Nonalcoholic fatty liver disease is associated with low circulating levels of insulin-like growth factor-I. <i>J Clin Endocrinol Metab<\/i> 96: E1640-1644.","DOI":"10.1210\/jc.2011-1227"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66. Volzke H, Nauck M, Rettig R, Dorr M, Higham C, Brabant G, Wallaschofski H (2009) Association between hepatic steatosis and serum IGF1 and IGFBP-3 levels in a population-based sample. <i>Eur J Endocrinol<\/i> 161: 705-713.","DOI":"10.1530\/EJE-09-0374"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67. Garcia-Galiano D, Sanchez-Garrido MA, Espejo I, Montero JL, Costan G, Marchal T, Membrives A, Gallardo-Valverde JM, Munoz-Castaneda JR, Arevalo E, De la Mata M, Muntane J (2007) IL-6 and IGF-1 are independent prognostic factors of liver steatosis and non-alcoholic steatohepatitis in morbidly obese patients. <i>Obes Surg<\/i> 17: 493-503.","DOI":"10.1007\/s11695-007-9087-1"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68. Tateno C, Kataoka M, Utoh R, Tachibana A, Itamoto T, Asahara T, Miya F, Tsunoda T, Yoshizato K (2011) Growth hormone-dependent pathogenesis of human hepatic steatosis in a novel mouse model bearing a human hepatocyte-repopulated liver. <i>Endocrinology<\/i> 152: 1479-1491.","DOI":"10.1210\/en.2010-0953"},{"key":"69","doi-asserted-by":"publisher","DOI":"10.1210\/er.22.1.53"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/59\/11\/59_EJ12-0322\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T06:36:19Z","timestamp":1618295779000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/59\/11\/59_EJ12-0322\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":69,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej12-0322","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]}}}